中國體檢市場-(沙利文)-中文版課件

中國體檢市場獨(dú)立研究?2015Frost&Sullivan.Allrightsreserved.ThisdocumentcontainshighlyconfidentialinformationandisthesolepropertyofFrost&Sullivan.

Nopartofitmaybecirculated,quoted,copiedorotherwisereproducedwithoutthewrittenapprovalofFrost&Sullivan.HighlyConfidentialApril,2015Shanghai,ChinaOverviewofEpidemiologyinChinaThemostcommonchronicdiseasesinChinaincludecardio-cerebrovasculardiseases,respiratorydiseases,anddiabetes,whicharetheleadingcausesforthedeathofChinesepeople.AccordingtotheNHFPC,almost80%ofthedeathsinChinaarefromchronicdiseases,whileheartdiseases,stroke,andrespiratorydiseasesaccountforaround75%ofthetotaldeath.In2012,atleast1outof5Chineseadultshassufferedfromatleastonechronicdisease,suchashypertensionanddiabetes.TheWHOestimatedthatChinesepatientswillspendmorethanUSD500billionforchronicdiseasetreatmentannuallyfrom2015.AccordingtotheNHFPCstatistics,malignancyranksthefirstamongallthediseasesthatcausedeathsinChina.Lungcancerandgastriclivercoloncanceraretheleadingtypesofcancerforthemalepopulation,whilebreast,lung,colon,gastricandlivercancerarethemostcommontypesofcancerforfemale.HepatitisBisthelargestproblemforinfectiousdiseasepreventioninChina.ThenumberofchronicasymptomaticHepatitisBviruscarriersreach120million,accountingforalmost9.75%ofthetotalpopulation.ThenumberofnewHepatitisBpatientsreached1.09millionin2012,0.96millionin2013,and0.94millionin2014,representingahighmorbidityintermsofthatoftotalviralhepatitisforeachyear.Meanwhile,HepatitisBisamajorfactortoincreasetheincidenceoflivercancerandotherliverdiseases.Source:NHFPC,ProfessionalMediasChronicDiseasesFatalDiseasesInfectiousDiseases中國流行概況中國最常見的慢性病包括心腦血管疾病、呼吸道疾病和糖尿病，慢性病已成為中國人死亡的主要原因中國衛(wèi)計(jì)委的數(shù)據(jù)顯示，在中國，80%的死亡由慢性病引發(fā)，其中心臟病、中風(fēng)和呼吸道疾病致死人數(shù)占死亡總數(shù)的75%。2012年，中國每5個(gè)成人中就至少有一個(gè)患有1種級以上的慢性病，諸如高血壓、糖尿病等。世界衛(wèi)生組織估計(jì)2015年之后中國的慢性病患者的醫(yī)療支出將會超過5000億美元。據(jù)中國衛(wèi)計(jì)委統(tǒng)計(jì)，惡性腫瘤所導(dǎo)致的死亡人數(shù)在中國居于首位.中國男性群體主要的癌癥類型為肺癌和胃肝結(jié)腸癌。中國女性的常見的癌癥類型包括乳腺癌、肺癌、結(jié)腸癌、胃癌和肝癌。乙型肝炎是中國傳染病防治的最大難題。據(jù)悉，目前中國乙型肝炎病毒的攜帶者數(shù)量已經(jīng)接近總?cè)丝诘?.75%，為1200萬人。2012年新增乙肝患者109萬例，13年的數(shù)字為96萬，14年為94萬。就病毒性肝炎而言，乙肝的發(fā)病率非常高。此外，乙肝也是引發(fā)肝癌和其他肝臟疾病的主要因素之一。.Source:NHFPC,ProfessionalMedias慢性疾病絕癥傳染性疾病

中國體檢市場分析,2010-2019E

年均復(fù)合增長率

(2010-2014):25.9%年均復(fù)合增長率(2014–2019E):22.5%人們對健康的日益重視推動了中國體檢市場的快速增長,市場總額由2010年的295億元增長到2014年的741億元。此外，據(jù)估計(jì)2014年到2019年間，中國體檢市場的年均復(fù)合增長率將達(dá)到22.5%，預(yù)計(jì)2019年市場總額將達(dá)到2042億元。2014年，中國公立醫(yī)院占據(jù)了體檢市場82.9%的市場份額，規(guī)模為614億人民幣。Source:Frost&SullivanPrimaryResearch&AnalysisMajorProvidersofHealthCheckupServicesMedicalexaminationdepartmentsofmajorpublichospitalsaredepartmentsthatareestablishedbyhospitalstoprovidephysicalcheckupservicesforthepublic.Theyarebenefitedgreatlyfromthemedicalexpertiseofhospitalstaffs,aswellasexperienceindiagnosisandadvancedmedicaldevices.

MedicalExaminationDepartmentsofPublicHospitalsPrivatehealthcheckupcentresareprivatelyrunbycompanieswhichfocusonprovidingphysicalcheckupservicesforthecustomers.Theyareestablishedwithprivatecapitaltopurchaseprofessionalequipmentandemployprofessionalstaffs.Theymainlytargetcorporatecustomersandindividualswithaverage-to-highdisposableincome.PrivateProvidersofHealthCheckupServicesInChina,variousmedicalexaminationfacilitiesprovidehealthcheckupandotherrelatedservices.PublichospitalsandprivateprovidersofhealthcheckupservicesconstitutedthebackboneofChinaHealthCheckupMarketin2013,includingapproximately5,000publichospitalsandover500privateproviders,accordingtoFrost&Sullivan’sanalysisbasedontheNHFPCstatisticsandprimaryresearch.Alongwiththesepublichospitalsandprivateprovidersofhealthcheckupservices,someotherprivatemedicalinstitutionsplayaminorroleinChinaHealthCheckupMarket.Source:Frost&SullivanPrimaryResearch&Analysis體檢服務(wù)的主要供應(yīng)商大型公立醫(yī)院的醫(yī)學(xué)檢驗(yàn)中心是專門為公眾體檢而設(shè)立的部門.這些公立醫(yī)院擁有先進(jìn)的診療設(shè)備和豐富的經(jīng)驗(yàn)，醫(yī)護(hù)人員也具有較高水平的醫(yī)療衛(wèi)生水平，因此在體檢市場中占據(jù)優(yōu)勢。公立醫(yī)院的醫(yī)學(xué)檢驗(yàn)中心民營健康檢查中心由企業(yè)運(yùn)營，為顧客提供健康檢查服務(wù).，一般由民營出資購買專業(yè)設(shè)備、聘請專業(yè)人員。.它們主要的目標(biāo)客戶為公司客戶和那些可支配收入高于平均水平的個(gè)人客戶。健康檢查的民營供應(yīng)商在中國，存在眾多的醫(yī)療體檢機(jī)構(gòu)為民眾提供健康體檢和其他相關(guān)服務(wù)。2013年，公立醫(yī)院和民營提供商構(gòu)成了中國體檢市場的主力軍,據(jù)Frost&Sullivan的分析，大約有5000家公立醫(yī)院和超過500家民營體檢機(jī)構(gòu)參與其中。除公立醫(yī)院和民營體檢機(jī)構(gòu)外，一些其他醫(yī)療機(jī)構(gòu)參與其中，但份額很小。Source:Frost&SullivanPrimaryResearch&AnalysisAnalysisofChinaPrivateHealthCheckupMarket,2010-2019EThePrivateHealthCheckupMarketinChinahasexperiencedarapidgrowthinthelastfiveyears,withasignificantincreaseintherevenuefromRMB4.3billionin2010toRMB12.7billionin2014.Inthecomingdecade,benefitingfromtherisingawarenessofpublichealth,theageingpopulationandthegovernmentderegulation,theprivatehealthcheckupmarketisexpectedtoseeanupwardtrend,growingataCAGRof28.6%from2014to2019.ThemarketsizeisforecastedtoreachapproximatelyRMB44.5billionin2019.AccordingtothepublicresourcesandFrost&Sullivan’sstudy,inrecentyearscorporateclientsaccountforalmost80%oftheprivatehealthcheckupmarketintermsoftheamountofphysicalcheckup.Onaverage,thepercapitaexpenditureofcorporateclientsislowerthanthatofindividualclients.Unit:RMBBillionSource:Frost&SullivanPrimaryResearch&Analysis中國民營體檢市場的競爭態(tài)勢民營體檢市場前4大的機(jī)構(gòu)總共占據(jù)了34.3%的市場份額，由此看來，中國民營體檢市場的市場集中度較低。通過聚焦高端客戶，愛康國賓的收入總額占據(jù)了中國民營體檢市場的榜首，美年大健康、慈銘體檢和瑞慈體檢緊隨其后。

慈銘體檢，是愛康體檢在中高端客戶市場的重要競爭者。國內(nèi)股票市場IPO的失敗，對其市場擴(kuò)張的步伐造成了較大的不利影響。注:所有數(shù)據(jù)精確到十分位.Source:Frost&SullivanPrimaryResearch&Analysis,CompanyDataKeyIssuesInProvidingHighQualityHealthCheckupServicesDigitalRadiologyUltrasoundMajorLabIVDDevice*Playersintheprivatesectorareimprovingtheircapabilitiesofprovidinghighqualityhealthcheckupservicestocatertotheunmetneedsofmiddleclassandhighclassdomesticcustomers.Thequalityofhealthcheckupservicesisdeterminedbymedicaldevices,thetechniqueandexperienceofthedoctors.BoththemedicalimagingdevicesintheclinicsandtheIVDdevicesinthecentrallabarecriticaltotheaccuracyofcheckupresults.Therefore,privatehealthcheckupcentersareinvestingheavilyonhigh-endmedicaldiagnosticdevices,suchasiKangandRichHealth.RMB61ischargedforreagentandrelatedservicesforeachpersoniniKang.Bycomparison,reagentandrelatedservicescostRMB29percapitainHealth100.MostarefromGPS*LessthanhalfarefromGPS.Themajorityarelocalbrands.MostarefromGPS.MostarefromGPSAbouthalfarefromGPS.Abouthalfarelocalbrands;Startedtoaddlow-endultrasoundfrominternationalbrandsMostarefromGPS.MostareMNCbrands(i.e.Roche,Siemens,Sysmex).LessthanhalfareMNCbrands.Themajorityarelocalbrands.Mostarelocalbrands.AmajorityareMNCbrands.MostoftheimmunetestsuseRoche/Siemensreagents.Amajorityarelocalbrands.Mostoftheimmunetestsuselocalbrandreagents.Mostarelocalbrands.Mostoftheimmunetestsuselocalbrandreagents.Mostarelocalbrands.Manyofitsimmunetestsareoutsourcingtolocal3rd-party.NOTE:GPSreferstoGE,Philips,andSiemens,whicharewellrecognizedasthebestmedicalequipmentmanufacturersglobally,providingcutting-edgeproductstothemedicalinstitutionsacrosstheworld.MajorlabIVDdevice/reagent:referstoImmuneAnalyzer,BiochemistryAnalyzer,andHematologyAnalyzer/theirreagents.MajorLabIVDReagent*Source:Frost&SullivanPrimaryResearch&Analysis150Packageprice,RMB1,0002,0003,00010,000GeneraltestininternalmedicineGeneraltestinsurgicaldept.GeneraltestinENTGeneraldentaltestBloodroutineUrineroutineChestradiographyECGRenalroutineBasicliverfunctionBasicbloodlipidHolisticliverfunctionHolisticbloodlipidBasictumormarkerMoreultrasoundinotherpartsHolisticthyroidalcheck-upMoretumormarkerMammographyMoreultrasoundinotherpartsCTHolistictumormarkerRheumatismBonemineraldensityMRIGastroscopePET-CTLowtoMid-endHighendHighendPremiumMosthealthcheckuppackagesinChinaarepricedbetweenRMB150-RMB1,000,whichprovideregularandroutinehealthcheckupitems.Thepriceofhigh-endpackagesrangesfromRMB1,000toRMB3,000,whichincludemoredetailedcheckupitems.Theaddeditemsvaryacrossdifferenthealthcheckupcenters.PremiumpackagesarepricedmorethanRMB3,000,whichusuallyincludeexpensivemedicalimagingexamination,suchasCT,MRI,andPET-CT.MostprivatehealthcheckupcompaniessetRMB1,000astheirthresholdpriceforVIPservices.PricingSegmentsofChinaHealthCheckupMarketSource:Frost&SullivanPrimaryResearch&Analysis150療程價(jià)格,人民幣1,0002,0003,00010,000內(nèi)科檢查（一般）外科檢查（一般）耳鼻喉檢查牙科檢查血常規(guī)檢查尿液常規(guī)檢胸部X線攝影心電圖腎功能檢查肝功能檢查（基本）血脂檢查（基本）肝功能整體檢查血液整體檢查基本腫瘤標(biāo)記其他部分的超聲波檢查甲狀腺整體檢查附加腫瘤標(biāo)記乳房X線照相術(shù)其他部分的超聲波檢查計(jì)算機(jī)斷層掃描腫瘤整體標(biāo)記風(fēng)濕病檢查

骨骼礦物密度核磁共振胃鏡正電子發(fā)射計(jì)算機(jī)斷層顯像低端—中端高端版高端版豪華版中國市場中，大多數(shù)體檢療程提供常規(guī)的體檢項(xiàng)目，價(jià)格在150-1000人民幣之間。高端療程提供了更細(xì)分的體檢項(xiàng)目，相應(yīng)的價(jià)格則定在1000-3000人民幣之間，不同的體檢中心的細(xì)分項(xiàng)目有所不同。豪華版療程則包括了諸如CT、MRI和PET-CT等昂貴的醫(yī)學(xué)成像檢測，因此要價(jià)高于3000元人民幣。大多數(shù)民營健康檢查機(jī)構(gòu)將VIP客戶的最低門檻設(shè)為1000元人民幣。中國體檢市場的價(jià)格分區(qū)Source:Frost&SullivanPrimaryResearch&AnalysisAverageSpendingonPhysicalCheckupServicesinChinaRMB200250300350400450500RMBRMBRMB200250300350400450500200250300350400450500200250300350400450500Inthepastfewyears,theaveragespendingonphysicalcheckupservicesintheprivatesectorhaswitnessedarisingtrend.In2014,iKang’saveragespendingofhealthcheckupservicesisthehighestamongthetop4players,sinceitmainlytargetsthemid-tohigh-endcustomersacrossthenation.TheaveragespendingofHealth100isthelowest(aboutRMB270),duetoitsmarketpositiontomeettheneedsofmid-tolow-endmarket.Source:Frost&SullivanPrimaryResearch&AnalysisAverageSpendingforPhysicalCheckupofLeadingPrivateProvidersofHealthCheckupServicesinChina,2014中國民眾體檢服務(wù)的平均支出RMB200250300350400450500RMBRMBRMB200250300350400450500200250300350400450500200250300350400450500在過去的幾年中，公眾在民營體檢中心的人均支出呈現(xiàn)上漲趨勢愛康國賓，主要瞄準(zhǔn)國內(nèi)的中高端消費(fèi)者，因此，2014年愛康國賓顧客人均支出在4個(gè)主要民營體檢供應(yīng)商中排名第一。美年大健康，主要客戶群體為國內(nèi)的中低端人群，因此其顧客的平均支出排名末位，為270元人民幣Source:Frost&SullivanPrimaryResearch&Analysis2014年中國主要的民營體檢中心顧客人均支出情況KeyEntryBarriersofthePrivateHealthCheckupMarketinChinaLicenseHumanResourceInitialInvestmentTheNHFPCannouncedtheInterimProvisionsonAdministrationofMedicalExaminationin2009toregulatethehealthcheckupindustry.Accordingtotheprovisions,allthemedicalexaminationcentersarerequiredtoobtainthelicenseofmedicalinstitute.Otherwise,itwouldbeconsideredasillegaltostartamedicalexaminationbusiness.AlsointheprovisionannouncedbytheNHFPC,eachmedicalexaminationcenterisobligatorytohaveatleast2chiefdoctorsinthecenter,and1vice-chiefdoctorineveryclinicalexaminationdepartment,and10registerednursesintotal.Accordingtoourresearch,themobilityofmedicalstaffsinChinaisrelativelylow;therefore,itisnoteasytoemployenoughqualifiedmedicalstaffs.Therearemainly3keyentrybarriersofthehealthcheckupindustry:Theinitialinvestmenttorunamedicalexaminationcenterisrelativelylarge,duetotherelativelyhighcostforrentfee,medicaldevicesandhumanresources.Anditwouldtakeyearstoreachbreakeven.Source:Frost&SullivanPrimaryResearch&AnalysisSummaryoftheGapBetweenDemandandSupplyinChinaHealthCheckupMarket---Publichospitals1ConsiderateandWarmAttitude2ComfortableandSafeEnvironment3HighQualityVIPServicesManycustomerscomplainthattheattitudeofdoctorsinpublichospitalsisnotgood.Doctorsinpublichospitalsareusuallylackofmotivationofgoodattitude.Andtheyaresometimesoverburdened.Sodoctorsinpublichospitalsusuallyshowtheirimpatiencetocustomers.Customershavelowerexpectationoftheservicequalityinpublichospitalsthanthatinprivatehealthcheck-upcenters,sincethebasicneedsforVIPservicesinhospitalsarenotsatisfied.One-on-oneservicesandprivateVIPspacearealwaysthebasicneedsforVIPservices.Butmanyhospitalsstillcannotprovidethoseduetolimitedreceptioncapacity.Highendcustomersalsohavestrongwillingnessofshorteninghealthcheckuptime.Butinrealitytheyhavetospendmoretimeinhospitalsthaninprivatehealthcheckupcenters.Manyimagingdiagnosisequipmentinpublichospitalsaresharedbyoutpatientandinpatient.Socustomerssometimeshavetomovefromthehealthcheckupareatooutpatie